帕金森病:对诱导多能干细胞的临床前研究的最新情况
V Valadez-Barba1, K Juárez-Navarro1, E Padilla-Camberos1
1Biotecnología Medica y Farmacéutica, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, Guadalajara, Jalisco, Mexico.
Neurologia
|October 20, 2023
概括
帕金森病 (PD) 是一种流行的神经退行性疾病. 使用诱导多能干细胞 (iPSC) 的新临床前模型为PD病变和潜在的治疗点提供了洞察力.
科学领域:
- 神经科学是一个神经科学.
- 干细胞生物学 干细胞生物学
- 神经学 神经学
背景情况:
- 帕金森病 (PD) 是全球第二大神经退行性疾病.
- 它涉及多巴氨基神经元和莱维体的损失,影响运动功能.
- 目前的治疗方法缺乏神经保护能力,PD病因仍然不清楚.
研究的目的:
- 探索诱导多能干细胞 (iPSC) 的实用性,以开发更精确的帕金森病临床前模型.
- 为了在体外研究PD病变的潜在机制.
- 确定新的治疗标和药物开发策略,用于帕金森病.
主要方法:
- 使用诱导多能干细胞 (iPSC) 来创建先进的临床前模型.
- 进行体外研究以分析PD的细胞和分子方面.
- 在iPSC衍生模型中研究多巴氨基神经元退化和勒维体形成.
主要成果:
- 从iPSC衍生的模型为详细研究PD病变发生提供了一个平台.
- 这些模型可以回顾帕金森病的关键病理特征.
- 使用iPSC模型进行的体外研究提供了有关疾病机制的宝贵数据.
结论:
- 诱导多能干细胞 (iPSC) 对推进帕金森病研究至关重要.
- iPSC 技术有助于开发更准确的临床前模型.
- 这种方法对发现PD的新治疗方法和治疗策略具有前景.
关键词:
细胞 troncales pluripotentes 诱导 的 诱导 的多巴氨基神经元是多巴氨基神经元.他患有帕金森氏症.诱导的多能干细胞干细胞一个模型预临床.神经衰退是一种神经衰退.神经退行发生神经退行.这些神经元是多巴胺基的.帕金森病是帕金森氏症的一种疾病.临床前模型是临床前模型.这是一个治疗方法.治疗方法 治疗方法更多相关视频
09:34Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring
Published on: August 6, 2020
7.3K
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
1.5K
相关概念视频
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Induced Pluripotent Stem Cells
24.0K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.0K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
